Organisation paid for research Program year 2025 Source: CMS Open Payments

Capital Area Research, LLC

Neither a doctor nor a teaching hospital

Research payments

$426,327

153 payments

Through program year 2025, Capital Area Research, LLC is reported as receiving $426,327 in research payments, across 153 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$260,190	31
2024	Research	$23,961	16
2023	Research	$3,218	11
2022	Research	$5,332	4
2021	Research	$14,483	11
2020	Research	$17,938	16
2019	Research	$101,205	64

Breakdown

Who paid Research payments · program years 2019–2025

Cleerly, Inc. $230,285 22 payments
Surmodics, Inc. $137,611 108 payments
Alnylam Pharmaceuticals Inc. $39,030 11 payments
Amarin Pharma Inc. $14,865 1 payment
Amgen Inc. $4,536 11 payments

Studies the money was for Research payments · program years 2019–2025

Transform $230,285 22 payments
Transcend $114,225 79 payments
Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3) $29,182 9 payments
A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the effect of AMR101 on Cardiovascular Heath and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardio $14,865 1 payment
Safety and Efficacy of the SurVeil Drug-Coated Balloon (TRANSCEND) $14,836 14 payments
A Phase 3 Global, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Zilebesiran in Addition to Standard of Care in Reducing Major Adverse Cardiovascular Events in Adult Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease $9,848 2 payments
Transcend $8,550 15 payments
Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure (METEORIC-HF) $1,610 6 payments
Vesalius-Cv $1,420 1 payment
Galactic-Hf $1,144 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.